ESR2 and triple-negative breast carcinoma: These novel data emphasize the functional role of EGFR signaling in modulating cell morphology in MDA-MB-231 (ERβ-positive) and shERβ MDA-MB-231 (ERβ-suppressed) triple-negative breast cancer cells.